CN105334203A - Kit for detecting enzymatic activity of biotinidase - Google Patents
Kit for detecting enzymatic activity of biotinidase Download PDFInfo
- Publication number
- CN105334203A CN105334203A CN201510831575.2A CN201510831575A CN105334203A CN 105334203 A CN105334203 A CN 105334203A CN 201510831575 A CN201510831575 A CN 201510831575A CN 105334203 A CN105334203 A CN 105334203A
- Authority
- CN
- China
- Prior art keywords
- reagent
- damping fluid
- buffer
- kit
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kit for detecting the enzymatic activity of biotinidase. The kit comprises a reagent 1, a reagent 2, a reagent 3, a reagent 4 and a reagent 5 which are have individual packages, wherein the reagent 1 is a buffer system formed by buffer solution 1 and enzyme activity stabilizer, and the pH value of the reagent 1 is 3-11; the reagent 2 is biocytin; the reagent 3 is stop buffer; the reagent 4 is neutralization solution; the reagent 5 is a system formed by buffer solution 2 and derived substrate, wherein the derived substrate is any of 1,2-diacetylbenzene, ninhydrin, fluorescamine and o-phthalaldehyde. When the kit is used for detecting, a dried-blood spot can be taken as a sample, so that the method can be applied to neonatal screening, and the requirement that biotinidase deficiency needs timely diagnosis and treatment is met; therefore, the kit is easy to popularize and use.
Description
Technical field
The present invention relates to a kind of kit detecting enzymatic activity, be specifically related to a kind of kit detecting biotin enzyme enzymatic activity, belong to biological medicine detection field.
Background technology
Biotin (Biotin) is also called Cobastab
7, biotin, biotin, be a kind of water miscible sulfur-bearing vitamin.Biotin is the coenzyme of 4 kinds of carboxylases in body, comprises the key enzyme pyruvate carboxylase in glycometabolism, the acetyl-CoA carboxylase of catalyze fatty acid synthesis first step reaction, the propionyl CoA carboxylase played an important role in protein metabolism and MCC.The shortage of biotin will cause above-mentioned enzymatic activity to lack, cause sugar, fat and protein three major nutrient metabolic disorder in body, there is mitochondria energy dyssynthesis, cause metabolic acidosis, organic aciduria and a series of nerve and integumentary system to damage, lethal time serious.In addition, biotin or the important ornamental equivalent of histone, participate in the processes such as gene expression and DNA repair.
Biotin enzyme is a kind of glycoprotein, is extensively present in the tissues such as serum, leucocyte, fibroblast and liver.The major function of biotin enzyme is in hydrolysing foodstuff and the biocytin that produces of organism metabolism and biotin-peptide, produces free biotin.Although biotin extensively exists in food, but the overwhelming majority exists with protein combination state, therefore, Biotinidase deficiency will cause body not only cannot absorb biotin from food but also cannot regenerate the biotin that organism metabolism produces, finally make body lack biotin, cause sugar, fat and protein metabolism in body abnormal, namely occur biotinidase deficiency (Biotinidasedeficiency, BD), also delayed Multiple carboxylase deficiency is claimed.
Biotinidase deficiency is a kind of autosomal recessive disease, age of onset generally at 1 thoughtful 10 years old, 3.5 months mean aves, but also to have after several years still non-evident sympton.Biotinidase deficiency complicated clinical manifestation, relates to nervous system, respiratory system, integumentary system, occurs growing delayed, eyesight and Hearing etc., and between patient, symptom differs greatly; Biochemistry is abnormal comprises metabolic acidosis, organic aciduria and hyperammonemia etc., occurs that stupor is even dead time serious.According to blood plasma residual biological element enzymatic activity size, biotinidase deficiency can be divided into two types, i.e. famine type (enzymatic activity <10% normal person mean value) and part shortage type (enzymatic activity is in 10% ~ 30% of normal person's mean value).According to the statistics of 1991, the global incidence of biotinidase deficiency was about 1/60,000, but different regions intercurrent disease rate is widely different, and such as Greece is up to 1/4, and 508, Turkey is 1/11,000,10, Europe the is national overall incidence of disease is 1/47,486.There is no morbidity statistics in China, 20 routine clinical case reports of only having an appointment, inferring according to case distribution, may there are differences between the south and the north at the incidence of disease of China in this disease.Oral free biotin can improve or stop the clinical symptoms of biotinidase deficiency, evident in efficacy and have no side effect.If can timely patient diagnosed, and supplement biotin throughout one's life and carry out prophylactic treatment, normal growth be grown and is not affected by patient, if but diagnosis is more late, and when there is growing the organic damages such as delayed, eyesight and hearing, these symptoms cannot be recovered.Therefore, making a definite diagnosis in early days and carry out prophylactic treatment, is the key of control biotinidase deficiency.
Because biotinidase deficiency complicated clinical manifestation is various, and in clinical manifestation, there is a lot of similarity (as fash etc.), easily by mistaken diagnosis with many Other diseases; In addition, part shortage type patient often only just shows symptom in pressurized (as infected) situation, therefore not easily find, but they exists onset risk all the time.If do not obtain correct diagnosis and treatment timely, cause a disease and fatal rate all higher.Therefore, set up the diagnostic method of biotinidase deficiency, make early diagnosis to patient, to improving biotinidase deficiency life in patients, to improve China population birth quality significant.
Biotinidase deficiency can carry out analyzing and diagnosing from 3 aspects, i.e. biotin enzyme enzyme activity assay, cylinder metabolism-ure horizontal analysis and genetic analysis, but the rear auxiliary or confirmation means that both can only diagnose as biotinidase deficiency.Because be difficult to biotinidase deficiency and Other diseases to carry out distinguishing (as holocarboxylase synthetase deficiency etc.) based on metabolite level, and metabolite level is often subject to the impacts such as morbidity state, diet and medication, the method such as tandem mass spectrum technology therefore analyzed based on metabolite level can only as the measure of biotinidase deficiency auxiliary diagnosis.For the analysis of gene level, owing to there is the reasons such as single nucleotide polymorphism, usually bring uncertainty to genetic analysis; On the other hand, the expression translation of gene and the realization of function often need participation or the modification of some other molecules or albumen, there is a lot of this kind of mechanism also completely not revealed at present, therefore genetic analysis as the reliable basis of diagnosis, can not be only applicable to the confirmation to biotinidase deficiency and somatotype.Then substantially there are not the problems referred to above in enzyme activity level analysis, not only specificity is high, and does not affect by morbidity state etc., therefore, to the diagnosis of biotinidase deficiency mainly based on the enzyme activity assay of biotin enzyme, it is the goldstandard of biotinidase deficiency diagnosis.
At present, the biotin enzyme activity assays adopted in the world is reaction substrate mainly with artificial substrates analog N-biotin-p-aminobenzoic acid, enzymatic activity is detected by the light absorption value of the derivant detecting its enzymatic hydrolysis product p-aminobenzoic acid, the method less expensive, but sulfa drugs can make testing result occur false negative.Another reaction substrate that can be used for the active examination of biotin enzyme is biotin-6-aminoquinoline, a kind of artificial substrates analog equally, enzymatic activity is detected by the fluorescent value detecting its enzymatic hydrolysis product aminoquinoline, the method cost is higher, and and some microbiotic can be used and occur false positive because of higher albumin concentration, in addition, high triglyceride concentration can make result occur false negative.It is substrate with fluorescence and radiolabeled biotin derivative etc. that other method also has, but all exist costly, the problem such as operation is more complicated, more time-consuming.It should be noted that in said method it is all using artificial substrates analog as reaction substrate, Ebrahim etc. study discovery, and during with natural substrate biocytin for reaction substrate, enzymatic activity comparatively artificial substrates is high by 30 ± 5%.Therefore, when taking biocytin as substrate, detection method has higher detection sensitivity and wider detectability, and more can the true horizon of biotin enzyme activity in reflected sample.
But the method that Ebrahim etc. set up can only be used for the detection of serum sample, sample consumption is large, and enzymatic activity is short for stabilization time, and also must carry out dialysis treatment to sample, complicated operation before detecting.Above deficiency causes the method to be applied to neonatal screening, but as previously mentioned, biotinidase deficiency must obtain diagnosis and treatment timely, otherwise will occur irreversible damage.
Summary of the invention
The object of this invention is to provide a kind of detection biotin enzyme (Biotinidase, EC3.5.1.12) kit of enzymatic activity, when kit of the present invention detects, be take biocytin as substrate, therefore there is higher detection sensitivity and wider detectability; And do not need to carry out any type of process in early stage to sample, can Enzyme assay be directly used in, convenient and swift; Kit of the present invention can be used on the fluorescence detection devices such as semi-automatic or full automatic fluorophotometer or microplate reader, more convenient.
The kit of detection biotin enzyme enzymatic activity provided by the invention, it comprises the reagent 1 of independent packaging, reagent 2, reagent 3, reagent 4 and reagent 5;
Described reagent 1 is the buffer system be made up of damping fluid 1 and enzyme stabilizing agent alive, and the pH value of described reagent 1 is 3 ~ 11;
Described reagent 2 is biocytin;
Described reagent 3 is stop buffer;
Described reagent 4 is neutralizer;
Described reagent 5 is the system be made up of damping fluid 2 and derivative substrate, and described derivative substrate is any one in 1,2-diacetyl benzene, triketohydrindene hydrate, fluorescamine and phthalic aldehyde.
In above-mentioned kit, in described reagent 1, the volumetric molar concentration of described damping fluid 1 can be 50 ~ 500mmol/L, and the volumetric molar concentration of described enzyme stabilizing agent alive can be 1 ~ 50mmol/L;
In described reagent 2, the volumetric molar concentration of described biocytin can be 0.05 ~ 2mmol/L;
In described reagent 3, the mass percentage of described stop buffer can be 30% ~ 70%;
In described reagent 4, the volumetric molar concentration of described neutralizer can be 0.2 ~ 2mol/L;
In described reagent 5, the volumetric molar concentration of described damping fluid 2 can be 50 ~ 500mmol/L, and the mass percentage of described derivative substrate can be 0.05% ~ 5%.
The concrete composition of kit provided by the invention can be: comprise the reagent 1 of independent packaging, reagent 2, reagent 3, reagent 4 and reagent 5;
Described reagent 1 is the buffer system be made up of damping fluid 1 and enzyme stabilizing agent alive, and the pH value of described reagent 1 is 5.5; The volumetric molar concentration of described damping fluid 1 can be 200mmol/L, and the volumetric molar concentration of described enzyme stabilizing agent alive can be 10mmol/L;
Described reagent 2 is biocytin, and the volumetric molar concentration of described biocytin can be 2mmol/L;
Described reagent 3 is stop buffer, and the mass percentage of described stop buffer can be 60%;
Described reagent 4 is neutralizer, and the volumetric molar concentration of described neutralizer can be 1mol/L;
Described reagent 5 is the system be made up of damping fluid 2 and derivative substrate, described derivative substrate is 1, in 2-diacetyl benzene, triketohydrindene hydrate, fluorescamine and phthalic aldehyde any one, the volumetric molar concentration of described damping fluid 2 can be 250mmol/L, and the mass percentage of described derivative substrate can be 1%.
In above-mentioned kit, described damping fluid 1 and described damping fluid 2 are all selected from least one in following buffer reagent:
A) sodium acetate-acetic acid damping fluid, pH is 2.6-5.8, b) sodium formate-formic acid buffer, pH is 2.0-5.0, c) citric acid-sodium citrate damping fluid, pH is 3.0-6.6, d) hydrophosphate-citrate buffer solution, pH is 2.2-8.0, e) hydrophosphate-citrate buffer, pH is 2.2-8.0, f) phosphate buffer, pH is 4.9-8.2, g) citric acid-sodium hydroxide-hydrochloride buffer, pH is 2.2-6.5, h) Tris-hydrochloride buffer, pH is 7.1-8.9, i) Glycine-NaOH damping fluid, pH is 8.6-10.6 and j) sodium carbonate-bicarbonate damping fluid, pH is 9.16-10.83,
In above-mentioned kit, described enzyme stabilizing agent alive can be MgSO
4, MgCl
2, disodium ethylene diamine tetraacetate, EDTAP dipotassium ethylene diamine tetraacetate, beta-mercaptoethanol, dithiothreitol (DTT), bovine serum albumin(BSA), at least one in glycerine and dimethyl sulfoxide (DMSO).
In above-mentioned kit, described stop buffer can be the aqueous solution of at least one in perchloric acid, hydrochloric acid, sulfuric acid, nitric acid and trichloroacetic acid.
In above-mentioned kit, described neutralizer can be the aqueous solution of at least one in sodium carbonate, sodium bicarbonate, NaOH, potassium hydroxide and calcium hydroxide.
When utilizing kit provided by the invention to detect biotin enzyme enzymatic activity, can carry out by the following method:
1) sample is added in described reagent 1 and described reagent 2 and reacts; Add described reagent 3 after reaction terminates and carry out cessation reaction; Described reacted system is carried out centrifuging, and in the supernatant obtained, add that described reagent 4 carries out being neutralized to pH value is 7 ~ 11; In the system after described neutralization, add described reagent 5 carry out derivatization reaction; Detect the fluorescent value of the system after described derivatization reaction under excitation wavelength 300 ~ 500nm and emission wavelength 400 ~ 600nm;
2) sample is added in described reagent 1 and reacts; After reaction end adds described reagent 2, add described reagent 3 immediately and carry out cessation reaction; Described reacted system is carried out centrifuging, and in the supernatant obtained, add that described reagent 4 carries out being neutralized to pH value is 7 ~ 11; In the system after described neutralization, add described reagent 5 carry out derivatization reaction; Detect the fluorescent value of the system after described derivatization reaction under excitation wavelength 300 ~ 500nm and emission wavelength 400 ~ 600nm, as the fluorescent value of blank;
Described reaction and step 1) described in the condition of reacting identical;
Described cessation reaction and step 1) described in the condition of cessation reaction identical;
Described derivatization reaction and step 1) described in the condition of derivatization reaction identical;
3) lysine of at least 8 kinds of variable concentrations is carried out described derivatization reaction with described reagent 5 respectively, and detect the fluorescent value of the system after described derivatization reaction under excitation wavelength 300 ~ 500nm and emission wavelength 400 ~ 600nm; With the concentration of lysine for horizontal ordinate, take fluorescent value as ordinate, production standard curve;
Described derivatization reaction and step 1) described in the condition of derivatization reaction identical;
4) according to step 1) in the fluorescent value that detects and step 2) in as the difference of the fluorescent value of blank and described typical curve, namely obtain step 1) in carry out the concentration of the lysine of described derivatization reaction, and then obtain the enzymatic activity of biotin enzyme in described sample;
The unit definition of described enzymatic activity is: micromole's number of the lysine generated with the described biocytin of every L sample hydrolysis per hour, is expressed as a μm ol/L/h.
In above-mentioned detection method, step 1) and step 2) in, described reagent 2 can be 1:1 ~ 99 with the volume ratio of described reagent 1, specifically can be 1:49; The temperature of described reaction can be 4 ~ 60 DEG C, and the time can be 0.5 ~ 48 hour, as reacted 24 hours under the condition of 37 DEG C.
In above-mentioned detection method, step 1) and step 2) in, in described cessation reaction, described reagent 3 is 1:20 with the volume ratio of reaction system.
In above-mentioned detection method, step 1) and step 2) in, in described neutralization procedure, the volume ratio of described supernatant and described reagent 4 can be 0.5 ~ 3:1, specifically can be 2:1;
In above-mentioned detection method, step 1) and step 2) in, in described derivatization reaction step, the volume ratio of described supernatant and described reagent 5 can be 0.5 ~ 2:1, specifically can be 1:1; The temperature of described derivatization reaction can be 4 ~ 60 DEG C, and the time can be 0.2 ~ 2 hour, as reacted 0.5 hour under the condition of 30 DEG C.
Step 3) in, described lysine standard concentration is 0 ~ 150 μm of ol/L, as 0,7.5,15,30,60,90,120 and 150 μm of ol/L.
Kit provided by the invention can be used for auxiliary diagnosis biotinidase deficiency.
Kit provided by the invention can be directly used in and detect dried blood spot sample, by by droplet of blood on the adsorbent material, and obtains after super-dry.Sorbing material used includes but not limited to the water-absorbing materials such as filter paper (conventional as 903# filter paper); Drying at drying at room temperature 4 ~ 16h, also can realize by other drying equipment dry a period of time.
When utilizing kit of the present invention to detect, in the dried blood spot sample used, biotin enzyme enzymatic activity can stablize time several months at ambient temperature, (as-20 DEG C) can stablize time several years under cryogenic, are therefore conducive to the examination of the preservation of sample, transport and biotinidase deficiency.
Kit provided by the invention can also be used for analysis and resolution and be derived from biotin enzyme enzyme activity in all kinds of samples (comprising various body fluid, cell or tissue and made dry plate thereof) of human body or animal, as can be used for the dry plate etc. of blood plasma, serum, leucocyte, cultured cell and preparation thereof, be suitable for sample scope wide.
Substrate in kit provided by the invention is biocytin (Biocytin, N-d-biotinyl-1B), and its general structural Formula is such as formula I:
It is the natural substrate of biotin enzyme, and compared with other substrate, this substrate has less Km value, and during with natural substrate biocytin for reaction substrate, enzymatic activity comparatively artificial substrates is high by 30 ± 5%, therefore has higher detection sensitivity and wider detectability.
Kit of the present invention is utilized to carry out the Cleaning Principle of biotin enzyme Enzyme assay as shown in following reaction equation:
Lysine+derivative reagent → lysine derivative
Biotin enzyme in sample can be hydrolyzed biocytin in suitable buffer system, generate lysine, react a period of time (0.5 ~ 48h) at suitable temperature (4 ~ 60 DEG C) after, add stop buffer in reaction system and make reaction terminating, supernatant is got after centrifugal, the lysine generated in course of reaction reacts with derivatization reagent and generates fluorescence-causing substance and lysine derivative, specifically excite with emission wavelength under the fluorescence that lysine derivative is special can be detected.Because the lysine amount generated is directly proportional to the fluorescence intensity of the fluorescence-causing substance of generation, therefore the lysine derivative fluorescent value under particular excitation wavelength and emission wavelength is detected, after deduction blank value, by reacting with lysine standard items and derivative reagent the typical curve prepared, the growing amount of lysine in reaction just can be calculated.
When using detection kit provided by the invention to detect, without the need to carrying out any type of process in early stage to sample, such as directly can add in reaction system with the small pieces that card punch takes off diameter 3mm on dried blood spot and can detect biotin enzyme activity, without the need to extracting biotin enzyme.And when adopting as other samples such as blood plasma, also without the need to dialysing to sample, ultrafiltration, the purification process such as chromatography, enzyme activity detection can be directly used in, convenient and swift.
When using detection kit provided by the invention to detect; the quantitative result of biotin enzyme activity in dried blood spot can be obtained; therefore may be used for the abnormal various diseases caused of enzyme activity of analysis, diagnosis and detection biotin enzyme; particularly by the enzyme activity exception of biotin enzyme or the similar various heredity of clinical symptoms and metabolic disease; as biotinidase deficiency, differentiate egg-white injury disease, holocarboxylase synthetase deficiency disease etc.
In a word, detection kit provided by the invention is used to detect, compared with the method (Ebrahim method) set up with Ebrahim etc., there is following advantage: first, when utilizing kit of the present invention to detect, can dried blood spot be detection sample, this makes this method can be applicable to neonatal screening, meet the requirement that biotinidase deficiency needs timely diagnosis and treatment, be easy to promote the use of.Secondly, when utilizing kit of the present invention to detect to sample without the need to carrying out the pre-treatments such as purification, not only expand detection sample range, also reduce Operating Complexity, Ebrahim method can only be used for serum specimen and detect, and must carry out dialysis treatment before detecting; 3rd, enzyme lives stability better, and in reaction system provided by the invention, the biotin enzyme activity stabilized time was more than 24 hours, and Ebrahim method is 3 hours; 4th, decrease sample and reagent dosage, reduce testing cost.
Accompanying drawing explanation
Fig. 1 is the typical curve between lysine concentration and the fluorescent value of lysine derivative made in embodiment 1.
Fig. 2 is that in embodiment 3, in dried blood spot, the hydrolysis of biotin enzyme catalytic substrate biocytin generates lysine amount and the linear relationship curve in reaction time.
Embodiment
The experimental technique used in following embodiment if no special instructions, is conventional method.
Material used in following embodiment, reagent etc., if no special instructions, all can obtain from commercial channels.
The detection kit of embodiment 1, biotin enzyme enzymatic activity and application
(1) detection kit of biotin enzyme enzymatic activity, comprises following component:
Reagent 1:
Sodium acetate-acetic acid damping fluid (pH5.5) 200mmol/L
Disodium ethylene diamine tetraacetate 10mmol/L (concentration in reagent 1)
Reagent 2:
Biocytin aqueous solution 2mmol/L
Reagent 3:
High chloro acid solution 60wt%
Reagent 4:
Na
2cO
3aqueous solution 1mol/L
Reagent 5:
Sodium carbonate-bicarbonate damping fluid damping fluid (pH9.0) 250mol/L
1,2-diacetyl benzene 1wt% (concentration in reagent 5)
(2) detection of biotin enzyme enzymatic activity
1) preparation of dried blood spot
The sample of biotin enzyme is dry blood spot, diameter is 3mm, prepares particular by following method: by the droplet of blood of health adult on 903# filter paper, at drying at room temperature 10h, obtain dry blood spot, the blood sample containing 10 μ L in every sheet dry blood spot.
2) detection of sample
Dry blood spot and reagent 2 is added in reagent 1, dry blood spot is not counted in reactant liquor volume, reagent 2 is 1:49 with the volume ratio of reagent 1, sample and reagent mixing make it to react, in 37 DEG C of reactions 24 hours, add reagent 3 cessation reaction after reaction terminates, reagent 3 is 1:20 with the volume ratio of reaction system.The centrifugal 10min of sample hose 10000g after stopping, gets supernatant, adds reagent 4, wherein the ratio of supernatant and reagent 4 is 2:1, and after neutralization, (pH is 9) adds reagent 5 again, and wherein the ratio of supernatant and reagent 5 is 1:1, derivatization reaction condition is 30 DEG C, lower reaction 30min.
Derivatization reaction terminates the fluorescent value of rear fluorescence detection device detection system under excitation wavelength 360nm (Ex=360nm) and emission wavelength 460nm (Em=460nm).
Said determination arranges 3 repetitions, and the fluorescence of health adult's dry blood spot sample reads value average out to 2085.33 as calculated.
3) mensuration of blank fluorescent value
Dry blood spot is added in reagent 1, dry blood spot is not counted in reactant liquor volume, mixing makes it to react, in 37 DEG C of reactions 24 hours, reagent 2 is added after reaction terminates, reagent 2 is 1:49 with the volume ratio of reagent 1, adds reagent 3 cessation reaction after adding reagent 2 immediately, and reagent 3 is 1:20 with the volume ratio of reaction system.The centrifugal 10min of sample hose 10000g after stopping, gets supernatant, adds reagent 4, wherein the ratio of supernatant and reagent 4 is 2:1, after neutralization, (pH is 9) adds reagent 5 again, and wherein the ratio of supernatant and reagent 5 is 1:1, and derivatization reaction condition is react 30min at 30 DEG C; Detect the fluorescent value of the fluorescent value of this system under excitation wavelength 360nm (Ex=360nm) and emission wavelength 460nm (Em=460nm) as blank.
Said determination arranges 3 repetitions, and the fluorescence of blank reads value average out to 651.67 as calculated.
4) drafting of typical curve
Get variable concentrations lysine standard items, its concentration is respectively 0,7.5,15,30,60,90,120 and 150 μm of ol/L, carries out derivatization reaction respectively with reagent 5, wherein the condition of derivatization reaction and step 2) in identical; Detect and the fluorescent value of system under excitation wavelength 360nm and emission wavelength 460nm after recording derivatization reaction; With the concentration of lysine for horizontal ordinate, take fluorescent value as ordinate, production standard curve, as shown in Figure 1.
According to the difference of made typical curve and the Mean Fluorescence of dry blood spot sample and the Mean Fluorescence of blank, calculate biotin enzyme enzymatic activity in health adult's blood, be 107.09 ± 4.16 μm of ol/L/h (n=3), wherein, the unit definition of enzymatic activity is: micromole's number of the lysine generated with the described biocytin of every L sample hydrolysis per hour, is expressed as a μm ol/L/h.
Result shows, the enzyme activity determination experimental result of sample is stable, and (CV value is less than 5%, learnt by the comparison in difference between Duplicate Samples), when illustrating that use kit of the present invention detects, effectively can detect the biotin enzyme enzymatic activity in dry blood spot sample.
The detection of embodiment 2, biotin enzyme enzymatic activity
With the volunteer of the biotinidase deficiency made a definite diagnosis through clinical diagnosis and genetic analysis for analytic target, take healthy volunteer as contrast.
Sample is dry blood spot, in the same manner as in Example 1.
Detection method is in the same manner as in Example 1, and each sample carries out 3 independently enzyme assay experiments respectively, and testing result is shown in Table 1.
The enzyme average alive of table 1 health adult and biotinidase deficiency patient
From the data in table 1, health adult's sample enzymatic activity is: 102.65 ± 9.17 (n=10); The enzyme activity of biotinidase deficiency patient only has 0.89% of health adult's control group, and the conclusion of this result and genetic analysis matches.Demonstrate kit provided by the invention when carrying out the detection of biotin enzyme enzymatic activity, there is stability, specificity, reliability, can be applicable to clinical detection relevant disease abnormal to biotin enzyme enzyme activity.
The detection of embodiment 3, biotin enzyme enzymatic activity
Sample is dry blood spot, in the same manner as in Example 1.
Detection method is in the same manner as in Example 1,6 group reactions are set altogether, often group is containing 2 samples and 2 blanks, and stop a group reaction respectively at 4h, 7h, 16h, 20h, 24h and 30h, then carry out derivatization reaction, and detect fluorescent value, investigate the stability of biotin enzyme in dried blood spot in course of reaction (as shown in Figure 2, linear equation is: y=73.97x+66.64, R
2=0.998).As can be seen from Figure 2, in 30h, the biotin enzyme enzymatic activity in dried blood spot is stablized, and testing result is reliable.
Claims (6)
1. detect a kit for biotin enzyme enzymatic activity, it is characterized in that: described kit comprises the reagent 1 of independent packaging, reagent 2, reagent 3, reagent 4 and reagent 5;
Described reagent 1 is the buffer system be made up of damping fluid 1 and enzyme stabilizing agent alive, and the pH value of described reagent 1 is 3 ~ 11;
Described reagent 2 is biocytin;
Described reagent 3 is stop buffer;
Described reagent 4 is neutralizer;
Described reagent 5 is the system be made up of damping fluid 2 and derivative substrate, and described derivative substrate is any one in 1,2-diacetyl benzene, triketohydrindene hydrate, fluorescamine and phthalic aldehyde.
2. kit according to claim 1, is characterized in that: in described reagent 1, and the volumetric molar concentration of described damping fluid 1 is 50 ~ 500mmol/L, and the volumetric molar concentration of described enzyme stabilizing agent alive is 1 ~ 50mmol/L;
In described reagent 2, the volumetric molar concentration of described biocytin is 0.05 ~ 2mmol/L;
In described reagent 3, the mass percentage of described stop buffer is 30% ~ 70%;
In described reagent 4, the volumetric molar concentration of described neutralizer is 0.2 ~ 2mol/L;
In described reagent 5, the volumetric molar concentration of described damping fluid 2 is 50 ~ 500mmol/L, and the mass percentage of described derivative substrate is 0.05% ~ 5%.
3. detection kit according to claim 1 and 2, is characterized in that: described damping fluid 1 and described damping fluid 2 are all selected from least one in following buffer reagent:
A) sodium acetate-acetic acid damping fluid, pH is 2.6-5.8, b) sodium formate-formic acid buffer, pH is 2.0-5.0, c) citric acid-sodium citrate damping fluid, pH is 3.0-6.6, d) hydrophosphate-citrate buffer solution, pH is 2.2-8.0, e) hydrophosphate-citrate buffer, pH is 2.2-8.0, f) phosphate buffer, pH is 4.9-8.2, g) citric acid-sodium hydroxide-hydrochloride buffer, pH is 2.2-6.5, h) Tris-hydrochloride buffer, pH is 7.1-8.9, i) Glycine-NaOH damping fluid, pH is 8.6-10.6 and j) sodium carbonate-bicarbonate damping fluid, pH is 9.16-10.83.
4. the kit according to any one of claim 1-3, is characterized in that: described enzyme stabilizing agent alive is MgSO
4, MgCl
2, disodium ethylene diamine tetraacetate, EDTAP dipotassium ethylene diamine tetraacetate, beta-mercaptoethanol, dithiothreitol (DTT), bovine serum albumin(BSA), at least one in glycerine and dimethyl sulfoxide (DMSO).
5. the kit according to any one of claim 1-4, is characterized in that: described stop buffer is the aqueous solution of at least one in perchloric acid, hydrochloric acid, sulfuric acid, nitric acid and trichloroacetic acid;
Described neutralizer is the aqueous solution of at least one in sodium carbonate, sodium bicarbonate, NaOH, potassium hydroxide and calcium hydroxide.
6. the application of kit according to any one of claim 1-5 in auxiliary diagnosis biotinidase deficiency.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510831575.2A CN105334203A (en) | 2015-11-25 | 2015-11-25 | Kit for detecting enzymatic activity of biotinidase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510831575.2A CN105334203A (en) | 2015-11-25 | 2015-11-25 | Kit for detecting enzymatic activity of biotinidase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105334203A true CN105334203A (en) | 2016-02-17 |
Family
ID=55284856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510831575.2A Pending CN105334203A (en) | 2015-11-25 | 2015-11-25 | Kit for detecting enzymatic activity of biotinidase |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105334203A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107807116A (en) * | 2017-10-24 | 2018-03-16 | 深圳中科唯新生物技术有限公司 | A kind of kit for detecting biotin enzyme enzymatic activity |
| CN107817233A (en) * | 2017-10-24 | 2018-03-20 | 深圳中科唯新生物技术有限公司 | A kind of method for detecting biotin enzyme enzymatic activity |
| CN109459428A (en) * | 2018-10-17 | 2019-03-12 | 迪瑞医疗科技股份有限公司 | A kind of lactate detection drying chemical reagent paper and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995033072A1 (en) * | 1994-06-01 | 1995-12-07 | Isolab, Inc. | Assay for enzyme activity using a microfluorometric assay |
-
2015
- 2015-11-25 CN CN201510831575.2A patent/CN105334203A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995033072A1 (en) * | 1994-06-01 | 1995-12-07 | Isolab, Inc. | Assay for enzyme activity using a microfluorometric assay |
Non-Patent Citations (3)
| Title |
|---|
| ESZTER SZABÓ ET AL.: "Quantitative Analytical Method for the Determination of Biotinidase Activity in Dried Blood Spot Samples", 《ANALYTICAL CHEMISTRY》 * |
| H. EBRAHIM ET AL.: "A Fluorometric Assay for Biotinidase", 《ANALYTICAL BIOCHEMISTRY》 * |
| KAZUNARI KUMASAKA ET AL.: "A new quantitative analytical method of serum biotinidase activity using biocytin as a substrate and its clinical significance in Japan", 《CLINICA CHIMICA ACTA》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107807116A (en) * | 2017-10-24 | 2018-03-16 | 深圳中科唯新生物技术有限公司 | A kind of kit for detecting biotin enzyme enzymatic activity |
| CN107817233A (en) * | 2017-10-24 | 2018-03-20 | 深圳中科唯新生物技术有限公司 | A kind of method for detecting biotin enzyme enzymatic activity |
| CN109459428A (en) * | 2018-10-17 | 2019-03-12 | 迪瑞医疗科技股份有限公司 | A kind of lactate detection drying chemical reagent paper and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fuller et al. | The dietary protein paradox and threonine 15N‐depletion: Pyridoxal‐5'‐phosphate enzyme activity as a mechanism for the δ15N trophic level effect | |
| Hansen et al. | The important role of taurine in oxidative metabolism | |
| Saudubray et al. | Neonatal congenital lactic acidosis with pyruvate carboxylase deficiency in two siblings | |
| ES2527306T3 (en) | Mass spectrometry methods for the simultaneous detection of metabolic enzyme activity and metabolite levels | |
| Eng et al. | Identification and assessment of markers of biotin status in healthy adults | |
| KR101948243B1 (en) | Euglobulin-based method for determining the biological activity of defibrotide | |
| CN101503732A (en) | Glucose oxidase single liquid detection reagent | |
| CN105296596A (en) | Enzymatic homocysteine detection kit with strong stability | |
| CN104120165B (en) | The homocysteine detection kit that a kind of stability is strong | |
| CN105334203A (en) | Kit for detecting enzymatic activity of biotinidase | |
| CN105372218A (en) | Method for detecting enzymatic activity of biotinidase | |
| CN105510583A (en) | Kit used for detecting enzyme activity of biotin enzyme | |
| JP2011506922A (en) | Methods and compositions | |
| CN105372219A (en) | Method for detecting enzymatic activity of biotinidase | |
| Bijarnia-Mahay et al. | Testing modalities for inborn errors of metabolism—what a clinician needs to know? | |
| CN101118237A (en) | A diagnostic test paper for cow subclinical ketosis | |
| CN103952461A (en) | Homocysteine detection kit with good repeatability | |
| CN105445468A (en) | Phenylalanine detection kit | |
| CN109097434B (en) | Sialic acid detection kit | |
| CN103397076B (en) | The application in the biochemical reagents of negative value or null value is there is in chlorate in preparation elimination measurement result | |
| CN103913440B (en) | A kind of pyruvate dehydrogenase complex enzyme activity detection reagent and its application | |
| CN106501244A (en) | Serum copper ions quantitative detecting reagent | |
| Konttinen | Simple method for determination of ornithine transcarbamylase activity in serum | |
| Kirchhof et al. | A historical perspective of the diagnosis of diabetes | |
| Shihabi et al. | Serum and tissue carnitine assay based on dialysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160217 |
|
| RJ01 | Rejection of invention patent application after publication |